- On average, a patient in Dubai has undergone 2.7 laboratory tests in 2017, as 11 .5 million inpatients and outpatients were encountered in Dubai
- More than 19,600 medical laboratory trade professionals expected to attend MEDLAB 2019 - the MENA region’s largest medical laboratory exhibition and congress - further boosting the clinical laboratory services market in the region
Dubai, United Arab Emirates: The MENA (Middle East & North Africa) region’s clinical laboratory services market is estimated to be worth around $8 - $10 billion – with approximately 60% - 70% of doctor’s decisions regarding a patients diagnosis, treatment, hospital admission and discharge now based on laboratory test results, according to a new report published ahead of MEDLAB 2019.
As one of the most important segments in the healthcare industry’s value chain, the research from Colliers International predicts the clinical laboratory services market in MENA is expected to grow at a CAGR of 6% - 8% until 2025 in line with global projections. Driving this growth is a paradigm shift towards preventative care rather than curative care, as well as the effect of key demand generators such as an ageing and increasing population, the emergence of lifestyle diseases and a high incidence of seasonal diseases.
Figures from the report titled “Clinical Laboratory Services in the MENA Region 2019” and published as part of the MEDLAB Market Report series, revealed the number of inpatients and outpatients in the UAE (Abu Dhabi and Dubai) is expected to grow from 29.3 million in 2016 to 95.3 million in 2030. Similarly, the UAE is projected to have a bed capacity of 25,300 by 2030, up from 12,500 in 2016.
In Dubai, public sector healthcare facilities conducted around 25.5 million tests in 2017 while the private healthcare sector performed over 6.2 million tests during the same period. On average, a patient in Dubai had undergone 2.7 laboratory tests in 2017 as 11.5 inpatients and outpatients were encountered in Dubai.
Commenting, Mansoor Ahmed, Director Healthcare, Education & PPP for MENA Region at Colliers International, said: “The increase in the number of patients will have a significant impact on the demand for clinical laboratory services in the UAE as the importance of the clinical laboratory industry continues to grow. Although the MENA clinical laboratory services market is still in a nascent stage, it has the ability to grow and catch up with the global market in the next few years.”
Mansoor also added: “Advancements in Information Technology (IT) will perhaps have the greatest impact on the clinical laboratory industry through improving and enhancing the accuracy and efficiency of laboratory operations, decreasing the average cost per test and decreasing the lead time to providing test results to the patients and doctors.”
Organised by Informa Exhibitions, MEDLAB Exhibition & Congress takes place from 4 – 7 February 2019 at the Dubai World Trade Centre and will welcome more than 19,600 medical laboratory trade professionals and 670 exhibitors from 46 countries in an effort to develop the value of laboratory medicine in shaping the future of healthcare.
“Last year, more than $166 million worth of deals were signed at MEDLAB highlighting the buoyancy of the clinical laboratory service market in the MENA region. As the status of the clinical laboratory industry continues to evolve, and new technologies and new medical tests are introduced in our laboratories, we will expect to see greater efficiency and improved patient services from the medical laboratories in the region,” said Tom Coleman, Group Exhibition Director, MEDLAB Series.
To download the “Clinical Laboratory Services in the MENA Region 2019” report, please visit https://www.medlabme.com/en/forms/mena-clinical-laboratory-services-2019-report.html
–Ends–
About MEDLAB
As the MENA region’s largest medical laboratory exhibition and congress, MEDLAB plays a crucial role in developing the value of laboratory medicine in shaping the future of healthcare by providing a platform for laboratory industry leaders, including manufacturers, dealers and distributors, to share best practice, showcase new innovations, collaborate and network.
MEDLAB stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Moving into its 3rd year as a stand-alone show, this annual medical laboratory meeting brings together exhibitors and attendees from 160 countries, giving them the opportunity to present the latest innovations, as well as access cutting-edge laboratory products and services.
A focus point of MEDLAB is its 11 CME-accredited multi-disciplinary conference tracks covering topics such as laboratory management, molecular diagnostics and genetics, and clinical chemistry. This year's congress will introduce three new tracks, covering immunology, Artificial Intelligence (AI) and Cytogenetics and IVF in an effort to provide advanced medical laboratory techniques for better health.
MEDLAB will take place from 4 - 7 February 2019 at the Dubai World Trade Centre, Dubai, UAE.
Website: www.medlabme.com
Facebook: www.facebook.com/medlabseries
Twitter: @MedlabSeries #MEDLABme
For more information, please contact Shamal Communications:
Media Contact
ASHLEIGH MCGINLEY
Senior Account Manager
Tel: +971 4 365 2715
E-mail: ashleigh.mcginley@shamalcomms.com
Office 106, Arjaan Office Tower, Dubai Media City
PO Box 502701 | Dubai, United Arab Emirates
Website: www.shamalcomms.com
A member of the WorldWisePR Affiliates
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
